One important metric to look for in a stock is an 80 or higher Relative Strength Rating. MaxLinear now clears that threshold, with a jump from 78 to 83 Monday.
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
MaxLinear is not currently showing a potential buy point. See if the stock goes on to build a base that could launch a new move.
The company showed 0% EPS growth last quarter. Sales rose -40%. Look for the next report on or around Jan. 29.
MaxLinear holds the No. 25 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom, NVIDIA and SiTime are among the top 5 highly rated stocks within the group.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
